Axon Enterprise, Inc $AXON Shares Newly Acquired by Norris Perne & French LLP MI

Norris Perne & French LLP MI purchased a new stake in Axon Enterprise, Inc (NASDAQ:AXON) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 6,878 shares of the biotechnology company’s stock, valued at approximately $2,906,000.

Several other large investors have also recently added to or reduced their stakes in the company. Rockefeller Capital Management L.P. grew its holdings in shares of Axon Enterprise by 53.2% during the fourth quarter. Rockefeller Capital Management L.P. now owns 11,518 shares of the biotechnology company’s stock worth $6,542,000 after purchasing an additional 4,002 shares during the last quarter. MassMutual Private Wealth & Trust FSB increased its stake in shares of Axon Enterprise by 122,993.6% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 461,601 shares of the biotechnology company’s stock valued at $195,036,000 after buying an additional 461,226 shares in the last quarter. B. Metzler seel. Sohn & Co. AG acquired a new stake in shares of Axon Enterprise in the second quarter valued at $3,854,000. Arrowstreet Capital Limited Partnership bought a new position in shares of Axon Enterprise in the first quarter valued at about $15,067,000. Finally, Brown Lisle Cummings Inc. raised its holdings in shares of Axon Enterprise by 97,231.4% in the second quarter. Brown Lisle Cummings Inc. now owns 34,066 shares of the biotechnology company’s stock valued at $19,098,000 after buying an additional 34,031 shares during the last quarter. 79.08% of the stock is owned by institutional investors.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 16,775 shares of the business’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the sale, the president directly owned 296,974 shares of the company’s stock, valued at approximately $170,590,774.82. The trade was a 5.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick Smith sold 10,000 shares of the business’s stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total value of $5,089,900.00. Following the sale, the chief executive officer directly owned 3,118,012 shares of the company’s stock, valued at $1,587,036,927.88. This represents a 0.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 47,397 shares of company stock valued at $26,722,984 in the last three months. Company insiders own 4.20% of the company’s stock.

Analysts Set New Price Targets

AXON has been the topic of several research reports. Royal Bank Of Canada reiterated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. Citigroup restated a “market outperform” rating on shares of Axon Enterprise in a research report on Thursday, September 17th. The Goldman Sachs Group dropped their target price on shares of Axon Enterprise from $715.00 to $675.00 and set a “buy” rating for the company in a research note on Monday, September 21st. Zacks Research raised shares of Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research note on Monday, October 5th. Finally, Argus upped their target price on shares of Axon Enterprise from $460.00 to $600.00 and gave the stock a “buy” rating in a research report on Thursday, September 3rd. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $689.94.

Axon Enterprise Stock Up 1.4%

Shares of AXON opened at $420.37 on Friday. The business’s fifty day moving average price is $480.64 and its two-hundred day moving average price is $473.90. The firm has a market capitalization of $34.15 billion, a price-to-earnings ratio of 174.43, a PEG ratio of 7.99 and a beta of 1.44. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $764.02. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. The company had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The firm’s quarterly revenue was up 35.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.12 earnings per share. On average, analysts predict that Axon Enterprise, Inc will post 2.10 earnings per share for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company’s portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.